GSK Share Price Performance
GSK Community Fair Values
- UK£16.52FV15.4% undervalued intrinsic discount4.10%Revenue growth p.a.2users have liked this narrative0users have commented on this narrative160users have followed this narrative6 days ago author updated this narrative
- UK£23.72FV41.1% undervalued intrinsic discount8.63%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative3users have followed this narrative7 days ago author updated this narrative
- UK£11.20FV24.7% overvalued intrinsic discount2.90%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative2users have followed this narrative6 days ago author updated this narrative
- DACommunity Contributor
GSK: March Madness Lineup
March Madness is here, or so they say on the basketball courts. But Marchs madness is slowly moving off to more than just the courts.UK£78.00FV82.1% undervalued intrinsic discount49.03%Revenue growth p.a.2users have liked this narrative2users have commented on this narrative15users have followed this narrative4 months ago author updated this narrative
Recent GSK News & Updates
No updates
GSK plc Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Jul 30, 2025
- Earnings per share (EPS)
- 0.78
- Gross Margin
- 71.92%
- Net Profit Margin
- 10.00%
- Debt/Equity Ratio
- 135.0%
GSK plc Competitors
About GSK
- Founded
- 1715
- Employees
- 68629
- CEO
- WebsiteView website
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
U.K. Market Performance
- 7 Days: 0.9%
- 3 Months: 7.0%
- 1 Year: 6.8%
- Year to Date: 8.7%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 5.9% in that time. As for the longer term, the market has risen 6.8% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading